| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 16 | |
| #2 | China | 1 | |
| #3 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Machines | |
| #4 | Foods and drinks | |
| #5 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Unspecified technologies | |
| #5 | Microorganisms | |
| #6 | Enzymes | |
| #7 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Maeda Hiroaki | 8 |
| #2 | Nozaki Chikateru | 5 |
| #3 | Hirashima Masaki | 4 |
| #4 | Kimachi Kazuhiko | 3 |
| #5 | Hamamoto Takayoshi | 3 |
| #6 | Tokiyoshi Sachio | 3 |
| #7 | Takahashi Kazuhiko | 2 |
| #8 | Akiyama Katsuhiko | 2 |
| #9 | Naruse Takeshi | 2 |
| #10 | Nishiyama Kiyoto | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP1408113A1 | Human type antihuman ige receptor antibody and antibody fragment | |
| EP1386963A1 | Peptides having cytotoxicity inhibitory activity and method of screening these peptides having cytotoxicity inhibitory activity | |
| EP0914830A1 | Neovascularization inhibitor containing tissue factor pathway inhibitor | |
| EP0867450A1 | TFPI-related Peptides which inhibit growth of smooth muscle cells |